Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex.Market launches wholesale supplies from China

9/13/24 YDEX

SFI's share was acquired by a subsidiary of RussNeft

9/12/24 RNFT

Fesco launched a container train from Vladivostok to Togliatti

9/12/24 FESH

Yandex launched an analog of the Miro service

9/12/24 YDEX

Shareholders of Yandex approved dividends

9/11/24 YDEX

Bashkir chain TANTANA will use the Okolo franchise

9/11/24 X5

Aeroflot's passenger traffic in August grew by 13.4%

9/11/24 AFLT

X5 Retail Group is testing its own delivery using robots

9/11/24 X5

Magnit and Sambury launched Cenohit

9/11/24 MGNT

Promsvyazbank will enter the capital of CarMoney

9/11/24 CARM